BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6546053)

  • 1. Dosage regimens for citrate anticoagulants.
    Hester JP; McCullough J; Mishler JM; Szymanski IO
    J Clin Apher; 1983; 1(3):149-57. PubMed ID: 6546053
    [No Abstract]   [Full Text] [Related]  

  • 2. Discontinuous automated calcium supplementation during thrombocytapheresis with the haemonetics MCS+ version C.
    Valbonesi M; Bruni R; Florio G; Marghero A; Telani A; Varinelli I
    Transfus Sci; 2000 Oct; 23(2):165-6. PubMed ID: 11794132
    [No Abstract]   [Full Text] [Related]  

  • 3. Discontinuous automated calcium supplementation during thrombocytapheresis with the MCS+ version C. Absence of severe complication due to calcium deprivation in 4308 procedures.
    Valbonesi M; Capra C; Frisoni R; Varinelli I
    Transfus Apher Sci; 2004 Oct; 31(2):167-8. PubMed ID: 15501421
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment for the decline of ionized calcium levels during peripheral blood progenitor cell harvesting.
    Kishimoto M; Ohto H; Shikama Y; Kikuta A; Kimijima I; Takenoshita S
    Transfusion; 2002 Oct; 42(10):1340-7. PubMed ID: 12423519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of PLT collections from two apheresis devices.
    Bueno JL; Barea L; García F; Castro E
    Transfusion; 2004 Jan; 44(1):119-24. PubMed ID: 14692977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric large-volume leukapheresis: a single institution experience with heparin versus citrate-based anticoagulant regimens.
    Bolan CD; Yau YY; Cullis HC; Horwitz ME; Mackall CL; Barrett AJ; Malech HL; Rehak NN; Wayne AS; Leitman SF
    Transfusion; 2004 Feb; 44(2):229-38. PubMed ID: 14962314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of adverse citrate reactions during autologous large-volume PBPC apheresis by continuous infusion of calcium-gluconate.
    Buchta C; Macher M; Bieglmayer C; Höcker P; Dettke M
    Transfusion; 2003 Nov; 43(11):1615-21. PubMed ID: 14617323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor symptomatology and safety in blood cell separation procedures.
    Hester JP
    Prog Clin Biol Res; 1982; 88():115-24. PubMed ID: 6179100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled study of citrate effects and response to i.v. calcium administration during allogeneic peripheral blood progenitor cell donation.
    Bolan CD; Cecco SA; Wesley RA; Horne M; Yau YY; Remaley AT; Childs RW; Barrett AJ; Rehak NN; Leitman SF
    Transfusion; 2002 Jul; 42(7):935-46. PubMed ID: 12375668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and laboratory effects on donors of intermittent-flow centrifugation platelet-leukapheresis performed with hydroxyethyl starch and citrate.
    Strauss RG; Koepke JA; Maguire LC; Thompson JS
    Clin Lab Haematol; 1980; 2(1):1-11. PubMed ID: 6155239
    [No Abstract]   [Full Text] [Related]  

  • 11. Laboratory and clinical effects of the infusion of ACD solution during plateletpheresis.
    Olson PR; Cox C; McCullough J
    Vox Sang; 1977 Aug; 33(2):79-87. PubMed ID: 883248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional citrate anticoagulation for PrismaFlex continuous renal replacement therapy.
    Burry LD; Tung DD; Hallett D; Bailie T; Carvalhana V; Lee D; Ramganesh S; Richardson R; Mehta S; Lapinsky SE
    Ann Pharmacother; 2009 Sep; 43(9):1419-25. PubMed ID: 19690224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CITRATE TOXICITY AND THE USE OF ANTICOAGULANT ACID CITRATE DEXTROSE BLOOD FOR EXTRACORPOREAL CIRCULATION.
    JENNINGS ER; BELAND AJ; COPE JA; ELLESTAD MH; MONROE C; SHADLE OW
    Surg Gynecol Obstet; 1965 May; 120():997-1008. PubMed ID: 14269851
    [No Abstract]   [Full Text] [Related]  

  • 14. Course of plasma ionized calcium following rapid infusion of acid citrate dextrose solution.
    Killen DA; Gower RE; Grogan EL; Collins HA
    Surg Forum; 1969; 20():95-6. PubMed ID: 5383159
    [No Abstract]   [Full Text] [Related]  

  • 15. [Plasma-cytapheresis in patients and donors (prospects of Soviet-American cooperation].
    Kalinin NN; Khester DP
    Gematol Transfuziol; 1990 Mar; 35(3):26-30. PubMed ID: 2361584
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of plateletpheresis using two cell separators and identical donors.
    Bertholf MF; Mintz PD
    Transfusion; 1989; 29(6):521-3. PubMed ID: 2749875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosage and scheduling regimens for glucocorticoids.
    Winton EF; Vogler WR; Mishler JM
    J Clin Apher; 1983; 1(3):144-8. PubMed ID: 6546052
    [No Abstract]   [Full Text] [Related]  

  • 18. Heparin based anticoagulation during peripheral blood stem cell collection may increase the CD34+ cell yield.
    Sevilla J; González-Vicent M; Fernández-Plaza S; Madero L; Díaz MA
    Haematologica; 2004 Feb; 89(2):249-51. PubMed ID: 15003908
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased risk of citrate reactions in patients with multiple myeloma during peripheral blood stem cell leukapheresis.
    Adamski J; Griffin AC; Eisenmann C; Milone MC; Sachais BS
    J Clin Apher; 2010; 25(4):188-94. PubMed ID: 20818713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium supplement increase on the second day of sequential two day leukapheresis.
    Asai T; Shimizu N; Narita M; Kobayashi M
    Ther Apher; 2001 Dec; 5(6):466-70. PubMed ID: 11800082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.